Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical benzyl benzoate 25% vs permethrin 5% for scabies
DRKS00031062Phase 3Completed
- Sponsor
- University Hospital of Dermatology, Paracelsus Medical University
- Start
- Jan 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in scabies comparing Benzyl benzoate 25% emulsion with Permethrin 5% ointment (2 arms). Started Jan 2023; status: completed.
02
Drugs
benzyl benzoatepermethrin
03
Conditions
scabies
Beyond the preview
Go deeper on DRKS00031062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00031062.